Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash flows operating activities:
Net income	$ 2,950,882	$ 1,113,441
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	769,440	609,037
Amortization of operating right-of-use asset	63,896	60,793
Bad debt expense	516,694	291,630
Stock compensation expense	249,733	375,000
Gain on debt extinguishment	1,109,350	0
(Increase) decrease in:
Accounts receivables	(1,508,097)	(350,908)
Long-term receivables, prepaid and other assets	293,042	884,429
(Decrease) increase in:
Accounts payable	1,091,304	(187,291)
Accrued liabilities	549,537	(247,233)
Operating lease liability	(63,895)	(60,794)
Deferred revenue	(452,633)	(213,677)
Net cash provided by operating activities	3,350,553	2,274,427
Cash flows investing activities:
Purchase of property and equipment	(105,391)	(642,922)
Net cash used in investing activities	(105,391)	(642,922)
Cash flows financing activities:
Net increase in lines of credit	1,340,000	340,000
Common stock buyback/retirement	(508,243)	(2,158,471)
Proceeds from employee stock plan	114,430	120,923
Dividends paid	(439,833)	(439,833)
Payments on notes payable	(920,754)	(219,992)
Net cash used in financing activities	(414,400)	(2,357,373)
Net increase (decrease) in cash and cash equivalents	2,830,762	(725,868)
Cash and cash equivalents at beginning of period	20,345,330	18,609,423
Cash and cash equivalents at end of period	23,176,092	17,883,555
Supplemental disclosure of cash flow information:
Cash paid for income taxes	55,772	100,158
Cash paid for interest	76,700	16,042
Cash paid for operating leases	71,200	71,200
Supplemental disclosure of non-cash investing and financing activities:
Common stock to pay accrued liabilities	214,550	284,135
Dividends accrued on preferred stock	439,833	439,833
Right of use asset	$ 0	$ 862,741